−0.09 CNY
7.93 M CNY
256.01 M CNY
29.74 M
About SHANGHAI RIGHTONGENE BIOTECHNOLOGY
Sector
Industry
CEO
Hui Xiong
Website
Headquarters
Shanghai
Founded
2012
ISIN
CNE100005212
FIGI
BBG00VPCYWV5
Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. It offers leukemia-related fusion gene, human estimated glomerular filtration rate gene mutation, genotype, human rubella virus, small ureaplasma, herpes simplex virus type 12 nucleic acid, and hepatitis B virus gene mutation detection kits. The company was founded by Hui Xiong on February 17, 2012 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688217 is 19.13 CNY — it has decreased by −3.43% in the past 24 hours. Watch SHANGHAI RIGHTONGENE BIOTECHNOLOGY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI RIGHTONGENE BIOTECHNOLOGY stocks are traded under the ticker 688217.
688217 stock has fallen by −18.53% compared to the previous week, the month change is a −8.56% fall, over the last year SHANGHAI RIGHTONGENE BIOTECHNOLOGY has showed a −45.00% decrease.
688217 reached its all-time high on Jun 2, 2021 with the price of 133.67 CNY, and its all-time low was 12.38 CNY and was reached on Jul 24, 2024. View more price dynamics on 688217 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688217 stock is 6.36% volatile and has beta coefficient of 1.59. Track SHANGHAI RIGHTONGENE BIOTECHNOLOGY stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI RIGHTONGENE BIOTECHNOLOGY there?
Today SHANGHAI RIGHTONGENE BIOTECHNOLOGY has the market capitalization of 1.09 B, it has decreased by −13.53% over the last week.
Yes, you can track SHANGHAI RIGHTONGENE BIOTECHNOLOGY financials in yearly and quarterly reports right on TradingView.
688217 net income for the last quarter is −3.49 M CNY, while the quarter before that showed 8.69 M CNY of net income which accounts for −140.22% change. Track more SHANGHAI RIGHTONGENE BIOTECHNOLOGY financial stats to get the full picture.
Yes, 688217 dividends are paid annually. The last dividend per share was 0.18 CNY. As of today, Dividend Yield (TTM)% is 0.91%. Tracking SHANGHAI RIGHTONGENE BIOTECHNOLOGY dividends might help you take more informed decisions.
SHANGHAI RIGHTONGENE BIOTECHNOLOGY dividend yield was 0.50% in 2023, and payout ratio reached 126.76%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 501.00 employees. See our rating of the largest employees — is SHANGHAI RIGHTONGENE BIOTECHNOLOGY on this list?
Like other stocks, 688217 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI RIGHTONGENE BIOTECHNOLOGY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI RIGHTONGENE BIOTECHNOLOGY technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI RIGHTONGENE BIOTECHNOLOGY stock shows the sell signal. See more of SHANGHAI RIGHTONGENE BIOTECHNOLOGY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.